If you have grandchildren in school, or if you simply live in a community where children attend public or private schools, the sweeping changes happening right now in state vaccine policy are not just a parenting issue — they are a direct senior health issue. Falling childhood vaccination rates create what epidemiologists call a breakdown in herd immunity, and adults over 65 are among the most vulnerable when that protective barrier erodes. Understanding what is changing, why it matters, and what you can do to protect yourself through your Medicare coverage is essential reading for every beneficiary in 2026.
Here is the core of what is happening: all 50 states and the District of Columbia still technically require certain vaccines for school attendance, but the landscape is shifting rapidly beneath that headline. Every state requires MMR (measles, mumps, rubella), DTaP (diphtheria, tetanus, pertussis), polio, and varicella vaccines for school-age children. That has been the baseline for decades. What is changing is the exemption system — who can opt out, how easily, and with how much documentation — and, more significantly, whether states are even following the same federal vaccine recommendations they once did.
As of August 2026, 30 states and the District of Columbia have announced they will no longer follow the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommendations for one or more childhood vaccines. Even more striking, 27 of those states have delinked from CDC/ACIP recommendations for all childhood vaccines. This is an unprecedented shift in American public health policy, driven in part by the Trump administration's public questioning of vaccine safety and effectiveness and its efforts to reduce the number of recommended childhood vaccines. When states delink their school entry requirements from federal recommendations, the practical result is that children may enter schools without vaccinations that were previously considered standard — and the communities those children live in, including senior living facilities, churches, grocery stores, and medical waiting rooms, become measurably less safe.
The exemption picture is equally concerning. All states permit medical exemptions, which is appropriate — some children genuinely cannot be vaccinated due to immune conditions or allergies. But 45 states and DC also permit religious and/or personal belief exemptions, and since 2025, at least nine states have enacted changes that make those non-medical exemptions easier to obtain. In practical terms, this means reduced documentation requirements, eliminated review processes, or simplified paperwork that allows more families to opt out without meaningful barriers. Research consistently shows that easier-to-obtain exemptions lead directly to higher exemption rates, which in turn lead to lower overall vaccination coverage in a community. This is not a theoretical concern — it is a documented chain of cause and effect.
The consequences are already visible in disease data. Higher exemption rates have been associated with increased incidence of measles and pertussis (whooping cough) across the United States. National childhood vaccination rates have been falling since 2019, and researchers have determined that this decline is entirely attributable to the growth in non-medical exemptions — not to access problems, not to cost barriers, but to deliberate opt-outs. For Medicare beneficiaries, measles is not a childhood nuisance. In adults over 65, measles can cause severe pneumonia, encephalitis, and death. Pertussis in older adults can mean weeks of violent coughing that leads to rib fractures, hospitalization, and serious respiratory complications. These are not hypothetical risks.
According to CMS.gov data, Medicare covers adult immunizations under two separate pathways, and understanding which applies to you can mean the difference between a $0 vaccine and an unexpected bill. Under Medicare Part B, the flu shot, COVID-19 vaccines, and pneumococcal vaccines are covered at no cost to you — no deductible, no copay — when administered by a provider who accepts Medicare assignment. The hepatitis B vaccine is also covered under Part B for beneficiaries at medium or high risk. Under the Inflation Reduction Act provisions that took full effect in 2023, all vaccines recommended by ACIP are now covered at no cost under Medicare Part D as well, which means your MMR booster, Tdap (the adult pertussis-containing vaccine), shingles vaccine (Shingrix), and others are available through your Part D plan or Medicare Advantage drug benefit with zero cost-sharing. This was a landmark change that eliminated what had previously been a significant financial barrier for many seniors.
Data Snapshot: According to CMS.gov data, Medicare Advantage enrollment reached approximately 33.8 million beneficiaries in 2024, representing more than half of all Medicare enrollees. CMS star rating data for 2025 showed that preventive care measures — including vaccine administration rates — are weighted components of plan quality scores. Plans with higher star ratings (4 stars and above) are more likely to proactively reach out to members about recommended vaccines and preventive screenings. When comparing Medicare Advantage plans during the Annual Enrollment Period (October 15 through December 7), checking a plan's star rating on Medicare.gov's Plan Finder tool can help you identify which plans have stronger track records on preventive care delivery, including immunizations.
If you are enrolled in a Medicare Advantage plan in 2026, your vaccine coverage should mirror or exceed what Original Medicare provides, because federal law requires Medicare Advantage plans to cover all Part B and Part D benefits. However, the delivery mechanism matters. Some Medicare Advantage plans require you to use in-network pharmacies for Part D vaccines, and others may require a prescription from your primary care physician before a pharmacy will administer a vaccine at no charge. If you walk into an out-of-network pharmacy and ask for a Tdap booster without checking your plan's network first, you may face unexpected cost-sharing. The safest approach is to call the member services number on the back of your Medicare Advantage card and ask specifically: which pharmacies in my network can administer vaccines at no cost, and do I need a referral or prescription first?
For beneficiaries on Original Medicare with a standalone Part D plan, the same network rules apply to your drug plan's vaccine coverage. Your Part D plan's formulary should list all ACIP-recommended vaccines as covered with $0 cost-sharing, but the in-network pharmacy requirement still applies. Medicare.gov's Plan Finder allows you to search your specific plan's pharmacy network and confirm vaccine coverage before you go. If you are in a state where measles or pertussis outbreaks have been reported — and given current trends, that list is growing — getting your Tdap booster and confirming your MMR immunity status with a blood titer test (covered under Part B as a diagnostic lab service) is a concrete, actionable step you can take right now.
It is worth understanding the geographic dimension of this risk, because it is not uniform across the country. States that have delinked from CDC/ACIP recommendations and simultaneously loosened exemption requirements represent the highest-risk environments for disease transmission. If you live in or frequently visit one of the 27 states that have fully delinked from federal vaccine guidance, your community's herd immunity threshold may be eroding faster than national averages suggest. Conversely, states like California, New York, and Maine have historically maintained stricter exemption policies, though even those states are navigating political pressure to loosen requirements. Checking your state health department's current school vaccination coverage data — most publish annual reports — can give you a sense of local risk.
For seniors who are immunocompromised — whether due to cancer treatment, organ transplant medications, rheumatoid arthritis drugs, or other conditions — the stakes are even higher. If you cannot mount a full immune response to vaccines yourself, you depend almost entirely on the people around you being vaccinated. This is the population for whom herd immunity is not an abstraction but a literal lifeline. If your Medicare Advantage plan includes a care management program for chronic conditions, ask your care coordinator whether your vaccine status has been reviewed recently and whether any boosters are recommended given your specific health situation.
During the Open Enrollment Period (January 1 through March 31, 2026), beneficiaries who switched Medicare Advantage plans should verify that their new plan covers vaccines at in-network pharmacies near their home. Plan formularies and pharmacy networks can change year to year, and a pharmacy that was in-network under your 2025 plan may not be in-network under your 2026 plan. The next Annual Enrollment Period runs October 15 through December 7, 2026, and preventive care quality — including how a plan supports vaccine access — is a legitimate criterion to weigh when comparing plans. A plan with a 4-star or 5-star CMS rating has demonstrated stronger performance on preventive measures than a 2-star or 3-star plan, and that difference has real implications for how proactively you will be supported in staying current on immunizations.
Finally, if you have questions about your specific vaccine coverage, the most direct resources are your plan's member services line, Medicare.gov's Plan Finder tool, and your State Health Insurance Assistance Program (SHIP) counselor. SHIP counselors are free, unbiased, and trained to help you navigate exactly these kinds of coverage questions. You can find your local SHIP office at shiphelp.org. In a policy environment where the rules are changing faster than most people can track, having a knowledgeable advocate in your corner — at no cost — is one of the most practical tools available to Medicare beneficiaries right now.